NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Clinical-Trial Cannabis and Placebo has Been Shipped
Following receipt of an import permit from Health Canada, RTI, which is the contracted licensed distributor for NDSP, successfully shipped the placebo cannabis to Aqualitas, the Canadian licensed cannabis producer for...
Psychedelic Policy Briefing: Week of July 20th, 2026
This week in psychedelic policy: Texas moves ahead with state-funded ibogaine trials, Eli Lilly buys AtaiBeckley for up to $3.8 billion, a Miami Beach doctor faces a manslaughter charge, and a Diné Nation chapter asks...
A lost peyote document from 1619: 5 Questions for philosopher Osiris Sinuhé González Romero
Romero discusses what a recently discovered manuscript reveals about peyote in the 17th century.
JOURNEYS: A Film Experience & Live Conversation with the Filmmakers
Watch JOURNEYS your way—on Vimeo or in community—then join Psychedelics Today for a live Q&A discussion with the creative team. There are 2 options to experience this film before the live chat: 1) “Live Conversation (...
Q&A: Psychedelics, cannabis, GLP-1s and drug policy changes
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are ...
Soccer and Psychedelics Have A Very Similar Problem
Plus surrogate healing, amanitas, and pharmahuasca gummies. [...] Read More... The post Soccer and Psychedelics Have A Very Similar Problem appeared first on DoubleBlind Mag.
Rethinking Our Language Model for Regulation of Access to Plants and Substances Currently Classified as ‘Drugs’: How Words Shape Law, Rights, and Reality
Terms like “illegal drugs” or “drug control” circulate so naturally in courtrooms, newsrooms, and legislatures that they seem self-evident. Yet the law never regulates substances — it regulates the human access, pract...
Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis
This qualitative study (n=25) examined a hybrid group model combining psilocybin-assisted therapy with virtual community-of-practice sessions for people with terminal illness-related distress. Participants generally c...
Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors
This mouse study examined how psilocybin affects dendrites in the medial frontal cortex and found that it briefly increased calcium activity in apical dendritic tufts only during quiet wakefulness. The effect depended...
The Myth That Built Modern Bufo
This Week’s Sunday Insider: Modern Bufo culture wasn't built on ancient tradition…it was built on a myth that almost nobody bothered to fact-check.
A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults
This Phase I randomised, double-blind, placebo-controlled single-ascending-dose trial (n=56) in healthy adults tested low doses of psilocybin and found dose-related subjective effects and pupil dilation, but no seriou...
What Is Metaprogramming? A Practitioner’s Introduction
Ketamine-assisted therapist Rachel Turetzky explains metaprogramming: John Lilly's term for consciously rewriting the beliefs that run beneath awareness, and why the window a psychedelic opens closes fast without a fr...
If I Were Starting Psychedelics Today, Here's Exactly What I'd Read
Welcome to The Psychedelic Blog.
Can Someone Else Drink Ayahuasca to Heal You?
In the Shipibo tradition, the answer is yes — and the practice is ancient. [...] Read More... The post Can Someone Else Drink Ayahuasca to Heal You? appeared first on DoubleBlind Mag.
Spiritual Emergencies and Esalen
The history and future of a concept